Mindset Pharma Inc. (MSSTF)
Mindset Pharma Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.54, down 0.37% on the session, giving a market capitalisation of $54.5M. On trailing twelve-month figures it carries a trailing P/E of -4.29, a net margin of -425.2%. Its beta of -0.10 implies it has historically moved less than the broad market.
Headquartered in Toronto, Canada, Mindset Pharma Inc. is dedicated to the development and commercialization of psychedelic medications for the treatment of neurological and psychiatric conditions within Canada. A key component of their pipeline involves advancing MSP-1014, a specific psychedelic drug candidate.
Mindset Pharma Inc. is most often compared with the following Healthcare names: